United Kingdom’s Withdrawal from the European Union

Debate between Nick Thomas-Symonds and John Bercow

Friday 29th March 2019 Commons Chamber

[Nick Thomas-Symonds]

The purpose of the extension is always the critical issue. Let me just say, in respect of the issue of a—[Interruption.]

[Mr Speaker]

Order. Mr Seely, calm yourself. Your attempt to intervene was politely rejected. Do not holler across the Chamber, man. Calm yourself—Zen.

[Nick Thomas-Symonds]

I say to my hon. Friend that we have raised the idea of a comprehensive customs union for months and months. That has not been properly considered because of the Prime Minister; it is nothing to do with the Opposition. Let me be clear: we will never mortgage all our futures on the outcome of a Conservative party leadership contest which most Members have no control over at all and would have to sit back and watch.

Without the clarity and protections that we need in the political declaration, we should not approve this withdrawal agreement. Today’s vote is a shoddy gimmick from a desperate Government trying to hide away from the reality that a meaningful vote on the political declaration and the withdrawal agreement still needs to be brought back to the House. For months and months, the Prime Minister’s deal has simply created division and discord when we needed consensus on the way forward. The national interest is in building consensus for a future that protects the jobs and livelihoods of all our constituents. That is why the House should reject this motion.

Points of Order

Debate between Nick Thomas-Symonds and John Bercow

Monday 3rd December 2018 Commons Chamber

[Nick Thomas-Symonds (Torfaen) (Lab)]

On a point of order, Mr Speaker. I seek your guidance regarding how the House should proceed in pursuing the publication of the advice provided by the Attorney General to the Cabinet. It is clear to Opposition Members, and we believe to the overwhelming majority of the House, that the document provided does not constitute the final and full advice provided by the Attorney General to the Cabinet. More importantly, this does not comply with the motion of the House that you have ruled to be effective. Indeed, I suggest that in the course of his statement, the Attorney General has been quite open about the fact that he is not complying with the motion based on his belief that it is not in the national interest to do so.

My right hon. and learned Friend the Member for Holborn and St Pancras (Keir Starmer), the shadow Brexit Secretary, along with the Scottish National party’s foreign affairs and Europe spokesperson, the Liberal Democrat spokesperson on Brexit, the Deputy Leader of the Democratic Unionist party, the Plaid Cymru spokesperson on Brexit and the leader of the Green party in Parliament, have this afternoon written to you asking whether you would consider giving this House, at the earliest opportunity, the chance to debate and resolve whether this is a matter of contempt. It is clear to me that the Government have taken an unprecedented decision not to comply with the unanimous and binding decision of this House. Instead, they seem to be playing for time, hoping that contempt proceedings take longer than the timetable for the meaningful vote. But we as a House cannot allow that to happen. I therefore ask you to set out how we should proceed to resolve this vital matter.

[Mr Speaker]

I am grateful to the hon. Gentleman for his point of order and for his characteristic courtesy in giving me advance notice of his intention to raise it—[Interruption.] I shall ignore the sedentary chuntering, which is undertaken for no obvious benefit or purpose. I have only just seen the letter to which the hon. Gentleman refers. I shall give it immediate attention when I leave the Chair. Having sat through these exchanges, I intend to come to a rapid decision, which I will convey to the House before it rises tonight, or, if that proves impossible, at the earliest opportunity tomorrow. I hope that that is helpful to colleagues.

Collective Defined Contribution Pension Schemes

Debate between Nick Thomas-Symonds and John Bercow

1st reading: House of Commons
Wednesday 17th October 2018 Commons Chamber

[Mr Speaker]

I am very grateful to the right hon. Lady for her point of order. The short answer is that, no, I have had no indication that a Minister intends to come to the House to correct the record. As she will be well aware, every Member of this House, including every Minister, is responsible for the accuracy of what he or she says in this place. If it is thought that an error has been made, it is the responsibility of the erring Member to put the record straight. May I politely suggest that the right hon. Lady seeks to engage with the Minister today? She may well find that that provides some satisfaction. If that turns out not to be the case, I know of no Member more versatile and experienced in this place in ensuring that what she wants to be aired in the Chamber is aired in the Chamber. This matter will have to be resolved sooner rather than later—either privately or publicly. I hope that that is helpful to her.

[Nick Thomas-Symonds (Torfaen) (Lab)]

On a point of order, Mr Speaker. Since I came into this House, I have campaigned on greater access to off-patent drugs for people with the most serious conditions. In recent years, the drug repurposing group has produced a very important report on this, and many people are waiting to see whether the Government will act on its recommendations. I put in a written question to the Secretary of State for Health and Social Care, and the response I got was simply that there would be a Government response in due course. That was disappointing to many people. Mr Speaker, can you advise me on how I might get a more precise answer to the question?

[Mr Speaker]

Well, the opportunities available to the hon. Gentleman are very real. [Interruption.] They are almost endless, as the hon. Member for Vale of Clwyd (Chris Ruane) chunters from a sedentary position with due mindfulness of what he speaks. First, the hon. Member for Torfaen (Nick Thomas-Symonds) can table further questions to try to extract the information that he seeks and, secondly, if he is still dissatisfied he can of course seek an Adjournment debate on the matter. Who knows? He might find that his application for an Adjournment debate, which would give him an opportunity for concentrated focus on the subject and engagement with the responsible Minister, would bear fruit. I think we will leave it there for now. I hope that that is helpful to the hon. Gentleman and that he feels enlightened and inspired.

Counter-Terrorism and Border Security Bill

Debate between Nick Thomas-Symonds and John Bercow

3rd reading: House of Commons & Report stage: House of Commons
Tuesday 11th September 2018 Commons Chamber

[Nick Thomas-Symonds]

I beg to move, That the clause be read a Second time.

[Mr Speaker]

With this it will be convenient to discuss the following:

New clause 3—Access to a solicitor—

“(1) Schedule 8 of the Terrorism Act 2000 is amended as follows.

(2) In paragraph 7 leave out “Subject to paragraphs 8 and 9”.

(3) In paragraph 7A—

(a) leave out sub-paragraph (3),

(b) leave out sub-paragraph (6) and insert—

(c) in sub-paragraph (7) at end insert—

(d) leave out sub-paragraph (8).

(4) leave out paragraph 9.”

This new clause would delete provisions in the Terrorism Act 2000 which restrict access to a lawyer for those detained under Schedule 7.

Government amendments 6, 7, 19, 8 and 9.

Amendment 26, page 36, line 7, schedule 3, at end insert—

“(6A) The Investigatory Powers Commissioner (“the Commissioner”) must be informed when a person is stopped under the provisions of this paragraph.

(6B) The Commissioner must make an annual report on the use of powers under this paragraph.”

Government amendment 10.

Amendment 27, page 46, line 17, leave out “and 26”.

Amendment 28, page 46, line 26, leave out sub-paragraph (3).

Amendment 29, page 46, line 33, leave out sub-paragraph (6) and insert—

Amendment 30, page 46, line 37, at end insert—

“provided that the person is at all times able to consult with a solicitor in private.”

Amendment 31, page 47, line 29, leave out paragraph 26.

This amendment would delete provisions in the Bill which restrict access to a lawyer for those detained under Schedule 3 for the purpose of assessing whether they are or have been engaged in hostile activity.

Amendment 14, page 47, line 31, leave out “and hearing” and insert “but not hearing”.

Government amendments 11, 12 and 20 to 25.

[Nick Thomas-Symonds]

New clause 1 would make our continued participation in the European arrest warrant a negotiating objective of the Brexit negotiations. There can be little doubt about the value of the EAW to this country. The Security Minister will be aware, for example, that it was vital to apprehending the man who helped to organise and co-ordinate the London bombings of 7/7. According to the National Crime Agency, between 2010 and 2016, the UK issued 1,773 requests to member states for extradition under the EAW and received 78,776 from member states. Of those the UK issued, 11 related to terror offences, 71 to human trafficking, 206 to child sex offences and 255 to drug trafficking.

According to the Government’s own White Paper, more than 12,000 individuals have been arrested, and for every person arrested on an EAW issued by the UK, the UK arrests eight on EAWs issued by other states. Without the EAW, extraditions can cost four times as much and take three times as long. The Security Minister will of course be aware that in counter-terror investigations speed really is of the essence, and it is therefore vital that we set the objective of continuing to play a key role on the European security scene.

Kerslake Arena Attack Review

Debate between Nick Thomas-Symonds and John Bercow

Wednesday 28th March 2018 Commons Chamber

[Nick Thomas-Symonds (Torfaen) (Lab)]

I am grateful to my hon. Friend the Member for Manchester Central (Lucy Powell) for requesting this urgent question and that it was granted. It was sobering for us all to read the names of the victims at the start of the Kerslake report. Today, we think of them and of all those affected by the terrible attack in Manchester on 22 May 2017.

The review makes it clear that there is a lot to be proud of in the responses of the city region of Greater Manchester and of its emergency services. At the same time, however, it is entirely right that we learn lessons for the future. I agree with the Mayor of Greater Manchester, who said clearly that bereaved families must be at the heart of the process. Does the Minister agree that communication and procedures are central to those lessons? There was no shared communication across the agencies of the declaration of Operation Plato, and Greater Manchester fire and rescue service was left, in the words of the review, “outside the loop” and could not play a meaningful role in the response for nearly two hours. The first meeting of the strategic co-ordinating group could, the review said, have been held “earlier than 04:15 hrs”. The set-up of the casualty bureau was severely hampered by what is described as a

“the complete failure of the National Mutual Aid Telephony system provided by Vodafone.”

Vodafone has a national contract with the Home Office, so will the Minister examine that contract and the guarantees that can be secured from Vodafone to ensure that such a situation does not happen again—

[Mr Speaker]

Order. I am afraid that the hon. Gentleman has exceeded his time, so I think he is finished.

[Nick Thomas-Symonds]

I have one question.

[Mr Speaker]

One more question, the hon. Gentleman means.

[Nick Thomas-Symonds]

Just one more question.

[Mr Speaker]

Blurt it out, man.

UK/EU Future Economic Partnership

Debate between Nick Thomas-Symonds and John Bercow

Monday 5th March 2018 Commons Chamber

[Mr Speaker]

Let us hear from another very well-behaved person—in fact, a cerebral academic, I think. Nick Thomas-Symonds.

[Nick Thomas-Symonds (Torfaen) (Lab)]

I am most grateful for the compliments, Mr Speaker.

The Prime Minister has said that alignment is possible in two ways, either by having the same rules or by having the same consequences flowing from different rules. Which of those two categories will the automotive sector fit into, given that so many jobs in the country depend on it, not least in my constituency?

Oman, UAE and Iran

Debate between Nick Thomas-Symonds and John Bercow

Monday 11th December 2017 Commons Chamber

[Mr Speaker]

Order. May I just underline, admittedly for only the first time today, but for the umpteenth time in recent weeks, that Members who arrived in the Chamber after the statement began should not stand and expect to be called? That is a discourtesy to the House of Commons, so it must not happen.

[Nick Thomas-Symonds (Torfaen) (Lab)]

Nazanin Zaghari-Ratcliffe’s sister-in-law lives in my constituency, and local people have presented me with a petition for her release. May I press the Foreign Secretary directly? Did he request to see her personally, so that he could judge of her mental and physical wellbeing?

Points of Order

Debate between Nick Thomas-Symonds and John Bercow

Tuesday 31st October 2017 Commons Chamber

[Mr Speaker]

I am grateful to the right hon. Gentleman for his point of order and for his notice a few moments ago of his intention to raise it. The short answer is that I have received no indication from any Minister of an intention to come to the House to make a statement on that matter. However, not being unconscious of the indefatigability of the right hon. Gentleman, I am confident that if the matter is not brought to the House, he will try to ensure, by one means or t’other, that it is.

[Nick Thomas-Symonds (Torfaen) (Lab)]

On a point of order, Mr Speaker. I seek the advice of the Chair on a situation that has arisen with a constituency matter. Constituents bought tickets from an organisation known as Viagogo, and then wanted a refund for those tickets. They were unsuccessful in that, and sought the advice of my office. My office has been unsuccessful in contacting the organisation, whether via email, telephone call, or even being able to find an address to write to. I seek your advice, Mr Speaker, on what can be done to encourage this organisation to respond to my constituency office in standing up for my constituents.

[Mr Speaker]

Whether it is incompetence or discourtesy, one knows not, but I think that most people would be interested to know, because of course it could happen to the constituent of any Member. The Minister is poised ready like a panther to pounce, and it would be a pity to disappoint the right hon. Gentleman. Let’s hear the fella.

Oral Answers to Questions

Debate between Nick Thomas-Symonds and John Bercow

Monday 10th July 2017 Commons Chamber

[Mr Speaker]

Splendid.

[Nick Thomas-Symonds (Torfaen) (Lab)]

T8. Given that the Royal British Legion set out in the armed forces covenant annual report of last year its concerns about the mental health needs of veterans not being met as they should be, does the Secretary of State agree that we need a comprehensive approach to veterans’ mental health, not just in the weeks after they leave the service but throughout their lives?

Oral Answers to Questions

Debate between Nick Thomas-Symonds and John Bercow

Thursday 2nd February 2017 Commons Chamber

[Mr Speaker]

The operative words are “public purse” and “fees”. Can we stick to that? It would be helpful.

[Nick Thomas-Symonds (Torfaen) (Lab)]

If the Government were genuinely motivated to spend this money by wanting a definitive answer from the courts on a constitutional question, why did they not thank the judges in the divisional court in November for such a clear answer, instead of being in a position where the Justice Secretary had to be pressured into giving a lukewarm defence of them?

Oral Answers to Questions

Debate between Nick Thomas-Symonds and John Bercow

Thursday 8th December 2016 Commons Chamber

[Nick Thomas-Symonds (Torfaen) (Lab)]

rose—

[Mr Speaker]

It is very good to see the hon. Gentleman back in his place.

[Nick Thomas-Symonds]

Thank you, Mr Speaker. The independent review commissioned by the Prime Minister that the Solicitor General has referred to expressed concern about the insufficient quality and quantity of intelligence at national, regional and international level, which it is said hampers our operational response. What steps does the Solicitor General think can be taken to ensure that our exit from the European Union does not further hamper our operational response?

Business of the House

Debate between Nick Thomas-Symonds and John Bercow

Thursday 20th October 2016 Commons Chamber

[Mr Speaker]

Order. What is needed now are questions in single short sentences. If those are forthcoming they will be heard; if not, they will not be.

[Nick Thomas-Symonds (Torfaen) (Lab)]

I associate myself with the remarks made about Aberfan and about my late friend and colleague Jo Cox.

On Saturday I will be attending the Remission Possible ball in honour of my young, inspirational constituent Emily Clark, who sadly died from cancer earlier this year. May we have a debate on the particular needs of young cancer patients when they suffer that terrible disease?

Oral Answers to Questions

Debate between Nick Thomas-Symonds and John Bercow

Thursday 14th April 2016 Commons Chamber

[Mr Speaker]

I hope that the Attorney General of all people will not underestimate the scope of his scholarly cranium, because the hon. Member for Kettering (Mr Hollobone) clearly does not do so.

[Nick Thomas-Symonds (Torfaen) (Lab)]

A condition of our membership of the European Union is that we are also a signatory to the European convention on human rights. Can the Attorney General confirm that this Government are committed to remaining a signatory to the convention and not to join Belarus, the only European country that is not a signatory?

Oral Answers to Questions

Debate between Nick Thomas-Symonds and John Bercow

Wednesday 13th April 2016 Commons Chamber

[Mr Speaker]

I think that the hon. Gentleman was referring to the Secretary of State for Defence, the right hon. Member for Sevenoaks (Michael Fallon). Some name was mentioned, but it does not mean anything in the Chamber.

[Nick Thomas-Symonds (Torfaen) (Lab)]

Since 2012, Jobs Growth Wales has helped 15,000 people into meaningful employment. Given that youth unemployment is falling faster in Wales than in the UK as a whole, does the Minister agree that the UK Government could learn from the Welsh Labour Government in this regard?

Access To Medical Treatments (Innovation) Bill

Debate between Nick Thomas-Symonds and John Bercow

Friday 29th January 2016 Commons Chamber

[Nick Thomas-Symonds (Torfaen) (Lab)]

I beg to move, That the clause be read a Second time.

[Mr Speaker]

With this it will be convenient to discuss the following:

New clause 2—Identifying evidence on off-patent repurposed drugs and passing to relevant bodies—

(1) The Secretary of State shall require the National Institute for Health Research to develop and introduce a mechanism for—

(a) gathering and recording existing evidence on off-patent, repurposed drugs, including clinical trial evidence, and

(b) passing this information to relevant bodies.

(2) The Secretary of State shall determine the relevant bodies under subsection (1) and may revise that determination from time to time.

New clause 3—Appraisal in new indications—

(1) Where there is an off-patent, repurposed drug with strong evidence of its effectiveness in a new indication, the Secretary of State shall direct the National Institute for Health and Care Excellence (NICE) to conduct an appraisal in relation to the drug in its new indication.

(2) An appraisal under subsection (2) should include a cost-effectiveness analysis.

New clause 4—National commissioning policy for off-patent new drugs—

Where there is an off-patent, repurposed drug with strong evidence of its effectiveness in a new indication, the Secretary of State shall require NHS England to produce and disseminate a national commissioning policy.

New clause 5—Accessibility of the licensing process—

(1) The Secretary of State shall require the Medicines and Healthcare products Regulatory Agency to consult key stakeholders about steps to be taken to make the licensing process more accessible to organisations or individuals other than pharmaceutical companies.

(2) For the purposes of subsection (1), key stakeholders shall include, but not be limited to—

(a) patient organisations,

(b) medical research charities,

(c) relevant academics, and

(d) the British Generic Manufacturers Association.

New clause 6—British National Formulary: inclusion of off-patent drugs—

The Secretary of State shall require NICE and the British National Formulary (BNF) to review their processes for registering off-label uses of repurposed drugs where there is strong evidence of their effectiveness.

Amendment 10, in clause 1, page 1, line 3, after “treatments” insert “(including treatments consisting in the off-label use of medicines or the use of unlicensed medicines)”

Amendment 13, in clause 5, page 3, line 44, at end insert—

“(1A) For the purposes of section 2(2), the kinds of medical treatment that may be innovative medical treatments include (amongst other things)—

(a) the off-label use of an authorised medicinal product, and

(b) the use of a medicinal product in respect of which no marketing authorisation is in force.

(1B) In subsection (1A)(a), the reference to the off-label use of an authorised medicinal product is a reference to the use of the product—

(a) for a purpose other than one for which its use is specified,

(b) in relation to a person who is not within a description of persons for whom its use is specified, or

(c) in any other way in which its use is not specified.

(1C) In this section—

(a) ‘authorised medicinal product’ means a medicinal product in respect of which a marketing authorisation is in force;

(b) ‘marketing authorisation’ and ‘medicinal product’ have the same meanings as in the Human Medicines Regulations 2012 (S.I. 2012/1916);

(c) ‘specified’, in relation to a medicinal product, means specified in its marketing authorisation.”

[Nick Thomas-Symonds]

These new clauses and amendments, which I support, relate to off-patent drugs. I think it would be useful for me briefly to set out the context in which they arise. The Off-patent Drugs Bill, a private Member’s Bill that I introduced—it was debated on Second Reading on 6 November—is a UK-wide Bill that would create a duty on the Government to make cheap drugs available when pharmaceutical companies had no incentive to do so. The problem, put simply, is that if a drug is shown to be useful for a new purpose after its original patent has expired, a pharmaceutical company has no financial incentive to sponsor that off-patent treatment through the processes normally used to license it and ensure its adoption on the NHS. Those off-patent or off-label treatments are certainly available at low cost. The issue is simply that although clinicians can of course prescribe them, they tend not to be prescribed consistently across the medical sector, or indeed geographically.

The Off-patent Drugs Bill ran out of time that day, but I think it is accurate to say that the Government supported its aims but not the mechanism it proposed. None the less, in recognising that there is a problem, and with a shared position on both sides of the House on the need to encourage greater consistency in off-label prescribing, a lot of work has since been done, and on a cross-party basis. I am proud that new clause 1 stands in the name of Members from no fewer than eight political parties. The concept of encouraging greater use of off-patent drugs, and indeed my Bill, have significant support across the House and outside. I pay tribute to Jonathan Evans, the former Member for Cardiff North, who first introduced such a Bill in 2014. His successor, the current Member for Cardiff North (Craig Williams), has also supported my Bill.